Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tscan Therapeutics, Inc.

1.80
+0.12007.14%
Post-market: 1.810.0100+0.56%19:44 EDT
Volume:213.36K
Turnover:380.84K
Market Cap:101.86M
PE:-0.77
High:1.83
Open:1.68
Low:1.66
Close:1.68
Loading ...

TScan Therapeutics Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
06 Mar

Promising Progress and Strategic Expansion Position TScan Therapeutics for Success

TIPRANKS
·
06 Mar

TScan Therapeutics Full Year 2024 Earnings: Misses Expectations

Simply Wall St.
·
06 Mar

BRIEF-TScan Therapeutics Inc Files For Mixed Shelf Of Up To $300 Million

Reuters
·
06 Mar

TScan Therapeutics Inc Files for Mixed Shelf of up to $300 Mln - SEC Filing

THOMSON REUTERS
·
06 Mar

TScan Therapeutics Is Maintained at Buy by Needham

Dow Jones
·
06 Mar

TScan Therapeutics Inc : Needham Cuts Target Price to $9 From $11

THOMSON REUTERS
·
05 Mar

TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
05 Mar

TScan Therapeutics Q4 2024 GAAP EPS $(0.30) Misses $(0.27) Estimate, Sales $665.00K Miss $1.35M Estimate, Cash, Cash Equivalents, And Marketable Securities Of $290.1M To Fund Operations Into Q1 Of 2027

Benzinga
·
05 Mar

BRIEF-TScan Therapeutics Q4 Net Income USD -35.809 Million

Reuters
·
05 Mar

TScan Therapeutics Q4 Collaboration and License Revenue USD 665 Thousand

THOMSON REUTERS
·
05 Mar

TScan Therapeutics Inc: Cash, Cash Equivalents, and Marketable Securities Continue to Fund Operations Into Q1 2027

THOMSON REUTERS
·
05 Mar

TScan Therapeutics Q4 Operating Expenses USD 37.377 Million

THOMSON REUTERS
·
05 Mar

TScan Therapeutics Q4 Net Income USD -35.809 Million

THOMSON REUTERS
·
05 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
05 Mar

TScan Therapeutics Announces Upcoming Presentation at the TD Cowen 45th Annual Health Care Conference

GlobeNewswire
·
27 Feb

TScan Therapeutics Insider Ups Holding By 18% During Year

Simply Wall St.
·
05 Feb

Barclays Sticks to Its Buy Rating for TScan Therapeutics (TCRX)

TIPRANKS
·
16 Jan

Here's Why TScan Therapeutics (TCRX) is Poised for a Turnaround After Losing -5.63% in 4 Weeks

Zacks
·
10 Jan

Sector Update: Health Care Stocks Edge Up in Afternoon Trading

MT Newswires Live
·
27 Dec 2024